These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Strategies for recombinant allergen vaccines and fruitful results from first clinical studies.
    Author: Cromwell O, Fiebig H, Suck R, Kahlert H, Nandy A, Kettner J, Narkus A.
    Journal: Immunol Allergy Clin North Am; 2006 May; 26(2):261-81, vii. PubMed ID: 16701144.
    Abstract:
    Recombinant DNA technology has delivered the prospect of a new generation of preparations for allergen-specific immunotherapy. The first clinical studies with recombinant allergens have yielded encouraging results, suggesting that there is a good chance that such preparations will become available for use in the routine management of allergic disease.
    [Abstract] [Full Text] [Related] [New Search]